New York Devil’s Claw Demand Returns DNA Barcoding To Industry Crosshairs
This article was originally published in The Tan Sheet
NY AG Schneiderman’s demands that 13 firms pull devil's claw supplements from the market impress supplement industry stakeholders no more than his February orders, also based on DNA barcoding alone, for GNC and three mass merchandizers to remove allegedly adulterated herbal supplements from stores.
You may also be interested in...
The court included its decision on Amarin’s ’s petition for a writ of certiorari among the single-line denials of nearly 200 appeals to consider decisions in civil litigation and convictions in criminal cases. However, Amarin still eyes curbing competition from omega-3 supplements.
Senate's Over-the-Counter Monograph Safety, Innovation, and Reform Act goes next for consideration by House, which has had a bill by the same title on its floor for a vote since it was passed by Energy and Commerce Committee in late June.